Patients Face High Out-of-Pocket Costs After Incident Cancer Diagnosis
By Elana Gotkine HealthDay Reporter
FRIDAY, July 25, 2025 -- Patients face high out-of-pocket costs (OOPCs) after an incident diagnosis of cancer, with costs increasing with stage of diagnosis, according to a study published online July 21 in JAMA Network Open.
Liam Rose, Ph.D., from the Stanford University School of Medicine in Palo Alto, California, and colleagues conducted a retrospective cohort study to examine OOPCs attributable to initial treatment of common cancers (breast, colorectal, and lung) among privately insured individuals diagnosed at different stages. The cohort included 46,158 patients younger than 65 years, including 19,656 with cancer and 26,502 without cancer (control group). Of those with cancer, 14,581; 2,842; and 2,233 patients had breast, colorectal, and lung cancer, respectively.
The researchers found that an incident cancer diagnosis was associated with a $592.53 per month mean increase in OOPCs for six months after diagnosis. There was a monotonic increase in cost with stage at diagnosis (mean OOPC increase ranged from $462.01 to $719.97 per month for stage 0 and 4, respectively).
"The variability in OOPCs based on cancer stage underscores the need for policies such as paid sick leave, that address both insurance continuity and financial assistance, especially for patients with more advanced cancer," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
FRIDAY, July 25, 2025 -- Antiobesity medications (AOMs) yield weight loss during use, followed by weight regain after discontinuation of treatment, according to a review published...
Exposure to PFAS Mixtures Linked to Increased Odds of Type 2 Diabetes
FRIDAY, July 25, 2025 -- In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D)...
More Than Half of Infants Diagnosed With HIV Did Not Receive Postnatal HIV Prophylaxis
THURSDAY, July 24, 2025 -- Although the rate of perinatal HIV infection is low, more than 50 percent of HIV infections in infants before age 1 year occurred in those who did not...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.